Literature DB >> 15936195

Is plasminogen deployed as a Streptococcus pyogenes virulence factor?

Mark J Walker1, Jason D McArthur, Fiona McKay, Marie Ranson.   

Abstract

Streptococcus pyogenes (group A streptococcus) causes human skin and throat infections as well as highly invasive diseases including necrotizing fasciitis. Group A streptococcal infections and invasive disease have made a resurgence in developed countries during the past two decades. S. pyogenes use multiple pathways for the acquisition and activation of human plasminogen, securing potent proteolytic activity on the bacterial cell surface. Recent experimental evidence using a humanized transgenic mouse model suggests a crucial role for human plasminogen in the dissemination of S. pyogenes in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15936195     DOI: 10.1016/j.tim.2005.05.006

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  42 in total

1.  Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone.

Authors:  Andrew Hollands; Morgan A Pence; Anjuli M Timmer; Sarah R Osvath; Lynne Turnbull; Cynthia B Whitchurch; Mark J Walker; Victor Nizet
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

2.  Severe skin and soft tissue infections and associated critical illness.

Authors:  Donald C Vinh; John M Embil
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

3.  Full time course kinetics of the streptokinase-plasminogen activation pathway.

Authors:  Miranda Nolan; Samantha D Bouldin; Paul E Bock
Journal:  J Biol Chem       Date:  2013-08-22       Impact factor: 5.157

4.  Streptococcus pyogenes M49 plasminogen/plasmin binding facilitates keratinocyte invasion via integrin-integrin-linked kinase (ILK) pathways and protects from macrophage killing.

Authors:  Nikolai Siemens; Nadja Patenge; Juliane Otto; Tomas Fiedler; Bernd Kreikemeyer
Journal:  J Biol Chem       Date:  2011-04-26       Impact factor: 5.157

5.  The plasminogen-binding group A streptococcal M protein-related protein Prp binds plasminogen via arginine and histidine residues.

Authors:  Martina L Sanderson-Smith; Mark Dowton; Marie Ranson; Mark J Walker
Journal:  J Bacteriol       Date:  2006-09-29       Impact factor: 3.490

6.  Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infection.

Authors:  Morag R Graham; Kimmo Virtaneva; Stephen F Porcella; Donald J Gardner; R Daniel Long; Diane M Welty; William T Barry; Claire A Johnson; Larye D Parkins; Fred A Wright; James M Musser
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

7.  Variable region in streptococcal M-proteins provides stable binding with host fibrinogen for plasminogen-mediated bacterial invasion.

Authors:  Kristofor Glinton; Julia Beck; Zhong Liang; Cunjia Qiu; Shaun W Lee; Victoria A Ploplis; Francis J Castellino
Journal:  J Biol Chem       Date:  2017-03-09       Impact factor: 5.157

8.  Antibiotic modulation of the plasminogen binding ability of viridans group streptococci.

Authors:  Cristina Teles; Andrew Smith; Sue Lang
Journal:  Antimicrob Agents Chemother       Date:  2011-10-28       Impact factor: 5.191

9.  A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptides.

Authors:  Andrew Hollands; David Gonzalez; Emma Leire; Cortny Donald; Richard L Gallo; Martina Sanderson-Smith; Pieter C Dorrestein; Victor Nizet
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

10.  The Streptococcus pyogenes serotype M49 Nra-Ralp3 transcriptional regulatory network and its control of virulence factor expression from the novel eno ralp3 epf sagA pathogenicity region.

Authors:  Bernd Kreikemeyer; Masanobu Nakata; Thomas Köller; Hendrikje Hildisch; Vassilios Kourakos; Kerstin Standar; Shigetada Kawabata; Michael O Glocker; Andreas Podbielski
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.